MICHAEL G MIKOLA

Allopathic & Osteopathic Physicians|Internal Medicine MT PLEASANT, SC NPI 1013969393

General Payments — all program years on this page

$7,155.48

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 393
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $409.11 across 11 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $409.1111

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $258.124
Amgen Inc. $46.952
Lilly USA, LLC $39.812
IDORSIA PHARMACEUTICALS US INC $24.901
ITI, Inc. $20.081
Novo Nordisk AS $19.251

By program year

Program yearAmountRecords
2018 $2,690.26167
2019 $2,476.88151
2020 $465.9324
2021 $272.3712
2022 $695.0720
2023 $145.868
2024 $409.1111

Records — PY2024 (11)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096893225 Novo Nordisk Inc $19.25 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105033675 ABBVIE INC. $124.99 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105033677 ABBVIE INC. $123.76 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105033679 ABBVIE INC. $4.55 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105033681 ABBVIE INC. $4.82 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115931630 Amgen Inc. $21.31 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117328279 Amgen Inc. $25.64 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135190663 Lilly USA, LLC $18.72 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135207096 Lilly USA, LLC $21.09 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143278608 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.08 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146768840 IDORSIA PHARMACEUTICALS US INC $24.90 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.